公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | Therapeutic drug monitoring and pharmacogenetic, study of HIV-infected ethnic chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapy | Lee K.-Y.; SHU-WEN LIN ; HSIN-YUN SUN ; CHING-HUA KUO ; Tsai M.-S.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; SUI-YUAN CHANG ; CHIEN-CHING HUNG | PLoS ONE | 24 | 25 | |
2020 | Therapeutic drug monitoring of the teicoplanin trough level after the loading doses in patients receiving venoarterial extracorporeal membrane oxygenation | Chen G.-J.; SHU-WEN LIN ; Tsai I.-L.; CHING-HUA KUO ; JANN-TAY WANG ; SZU-MIN HSIEH | Journal of the Formosan Medical Association | 5 | 5 | |
2021 | Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression | Huang, Wei-Chieh; Huang, Chun-Kai; Huang, Sung-Hsi; SHU-WEN LIN ; Ou, Shyh-Tyan; YI-TING CHEN ; Chen, Ya-Wen; Chang, Shu-Yuan; Liu, Wen-Chun; HSIN-YUN SUN ; CHIEN-CHING HUNG | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 1 | 1 | |
2024 | The timing of intravenous antibiotics and clinical outcomes of Mycobacterium abscessus complex lung diseases | Pang, A. H.; SHU-WEN LIN ; Yang, J. H.; Wang, P. H.; Pan, S. W.; Wei, Y. F.; CHUNG-YU CHEN ; Lee, H. S.; Wu, T. S.; Chang, C. H.; CHIN-CHUNG SHU | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease | | | |
2019 | Training Program Reformation May Improve Self-efficacy of Pharmacy Student | Jia-An Hung; FEI-YUAN HSIAO ; CHIA-YI WU ; FE-LIN LIN WU ; LI-JIUAN SHEN ; SHU-WEN LIN | Journal of Medical Education | | | |
2017 | Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study | Tsai M.-S.; SUI-YUAN CHANG ; SHU-WEN LIN ; CHING-HUA KUO ; HSIN-YUN SUN ; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 5 | 3 | |
2016 | Use of hypoprothrombinemia-inducing cephalosporins and the risk of hemorrhagic events: A nationwide nested case-control study | Chen L.-J.; FEI-YUAN HSIAO ; LI-JIUAN SHEN ; FE-LIN LIN WU ; WOEI TSAY ; CHIEN-CHING HUNG ; SHU-WEN LIN | PLoS ONE | 32 | 19 | |
2010 | Using sweeping-micellar electrokinetic chromatography to determine voriconazole in patient plasma | Lin, Shu-Chiao; SHU-WEN LIN ; Chen, Jhong-Min; CHING-HUA KUO | Talanta | | | |
2005 | Using topical agents to prevent MRSA infections in the ICU | Chenoweth C.E.; SHU-WEN LIN ; Depestel D.D. | Journal of Respiratory Diseases | 0 | | |
2005 | What topical decontamination regimens are most appropriate in the intensive care unit (ICU) when methicillin-resistant Staphylococcus aureus (MRSA) is a concern? | Chenoweth, CE; SHU-WEN LIN ; DePestel, DD | The Journal of Respiratory Diseases | | | |
2014 | 乳癌用藥手冊 | 姜紹青; SHU-WEN LIN ; 蔡振華; 鄭吉元; 謝玲玲; 蘇芳玉 | | | | |
2011 | 乳癌用藥手冊 | SHU-WEN LIN ; 蔡振華; 鄭吉元; 謝玲玲; 姜紹青 | | | | |
2013 | 大腸癌用藥手冊 | 姜紹青; SHU-WEN LIN ; 馮資喻; YEN-MING HUANG ; 蔡振華; 鄭吉元; 謝玲玲 | | | | |
2010 | 抗愛滋病毒藥物與抗結核病藥物之藥物動力學與副作用介紹 | SHU-WEN LIN | 愛之關懷 | | | |
2022 | 肺癌用藥 你該知道的事 | 臺大癌醫中心分院肺癌多專科診療團隊; JIN-SHING CHEN ; 莊仁豪; BIN-CHI LIAO ; 劉彥廷; YEN-TING LIN; ZONG-HAN YAO ; SHANG-GIN WU ; SHU-WEN LIN ; 何暐; 柯欣妏 | | | | |
2013 | 臺灣之畢業後藥學教育 | 黃淑慧; SHU-WEN LIN ; LI-JIUAN SHEN | 醫療品質雜誌 | | | |